Kory James Wentworth

Companies

• Entrada Therapeutics, Inc.Chief financial officer Oct 28, 2021 to now¹
• bluebird bioPrincipal Accounting Officer Dec 20, 2017 to Aug 5, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEntrada Therapeutics, Inc. TRDA117,277 shares³$564.1K at $4.81Sep 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Shares withheld for tax 1,733 shares at $7.14 of Entrada Therapeutics, Inc.³
• Apr 1, 2026Sold 2,500 shares at $12.95 of Entrada Therapeutics, Inc.⁴
• Mar 10, 2026Sold 11,388 shares at $13.02 of Entrada Therapeutics, Inc.⁵
• Mar 9, 2026Sold 5,089 shares at $13.00 of Entrada Therapeutics, Inc.⁵
• Mar 4, 2026Sold 7,988 shares at $12.25 of Entrada Therapeutics, Inc.⁶
• Mar 3, 2026Shares withheld for tax 5,712 shares at $11.76 of Entrada Therapeutics, Inc.⁷
• Mar 2, 2026Shares withheld for tax 2,939 shares at $11.66 of Entrada Therapeutics, Inc.⁷
• Mar 1, 2026Granted 44,600 shares of Entrada Therapeutics, Inc.⁷
• Nov 21, 2025Sold 8,910 shares at $9.98 of Entrada Therapeutics, Inc.⁸
• Sep 2, 2025Shares withheld for tax 1,734 shares at $5.43 of Entrada Therapeutics, Inc.⁹
• Apr 3, 2025Exercised options 11,134 shares at $2.10 of Entrada Therapeutics, Inc.¹⁰
• Mar 17, 2025Sold 1,784 shares at $10.67 of Entrada Therapeutics, Inc.¹¹
• Mar 3, 2025Shares withheld for tax 4,929 shares at $11.68 of Entrada Therapeutics, Inc.¹²
• Mar 1, 2025Granted 42,400 shares of Entrada Therapeutics, Inc.¹²
• Dec 2, 2024Sold 5,000 shares at $20.00 of Entrada Therapeutics, Inc.¹³
• Dec 2, 2024Exercised options 5,000 shares at $2.10 of Entrada Therapeutics, Inc.¹³
• Nov 29, 2024Sold 1,000 shares at $19.97 of Entrada Therapeutics, Inc.¹³
• Nov 29, 2024Exercised options 1,000 shares at $2.10 of Entrada Therapeutics, Inc.¹³
• Nov 11, 2024Sold 8,637 shares at $19.98 of Entrada Therapeutics, Inc.¹⁴
• Nov 11, 2024Exercised options 6,000 shares at $2.10 of Entrada Therapeutics, Inc.¹⁴
• Sep 9, 2024Sold 3,195 shares at $14.97 of Entrada Therapeutics, Inc.¹⁵
• Sep 5, 2024Shares withheld for tax 165 shares at $15.13 of Entrada Therapeutics, Inc.¹⁶
• Sep 4, 2024Shares withheld for tax 941 shares at $15.42 of Entrada Therapeutics, Inc.¹⁶
• Sep 3, 2024Shares withheld for tax 14 shares at $17.70 of Entrada Therapeutics, Inc.¹⁶
• Sep 3, 2024Shares withheld for tax 149 shares at $16.93 of Entrada Therapeutics, Inc.¹⁶